// COMPANY
Kailera Therapeutics
SECTOR BIOTECHMENTIONS 2LAST SEEN JUNE 11, 2026
// OVERVIEW
Bain Capital-backed biopharma company focused on obesity drugs that raised a $625M IPO.
// RECENT MENTIONS
// SIGNALS
2 SIGNALS
01
mention·PitchBook News·JUNE 11, 2026
“Parabilis Medicines has broken the record for the largest VC-backed biotech IPO, just weeks after Kailera Therapeutics took the crown.”
02
funding·PitchBook News·APRIL 20, 2026
“Kailera Therapeutics | Biopharma; obesity drug focus | Bain Capital-backed; raised $625M IPO”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.